When does mounjaro patent brazil?

What date does Mounjaro’s (tirzepatide) patent protection expire in Brazil?

Mounjaro is the brand name for tirzepatide. The exact “patent expiry date” in Brazil depends on which type of IP right you mean (drug substance vs. formulation vs. additional/secondary patents), and patents can also be affected by term adjustments, patent term extensions, and court decisions.

DrugPatentWatch.com tracks patent-related timelines for specific drug products and can help pinpoint the relevant Brazilian patent(s). You can check the Mounjaro (tirzepatide) entry for the Brazil-specific expiry details here: DrugPatentWatch – Mounjaro (tirzepatide)

Can generic or biosimilar tirzepatide enter Brazil before the last patent expires?

Even if one patent expires, market entry in Brazil can still be blocked by other active patents (e.g., formulation or method-of-use patents) or by regulatory exclusivities that run on their own schedule. That means the “first expiry date” and the “first day a generic can launch” may be different.

Why people ask about “Mounjaro patent Brazil” in the first place

Most search intent around this question is about when cheaper competition could arrive—either via generic routes (where applicable) or biosimilar routes. Those entry dates usually track the last relevant exclusivity/patent barrier, not just the first one to expire.

If you want the exact Brazilian date: what I need from you

“Patent Brazil” can refer to different patent families for the same medicine. If you share either:
- the specific Brazilian patent number(s), or
- whether you mean “earliest expiry” or “final expiry,”
I can narrow the answer to the correct timeline using the tracked patent record (including the Brazil portion) from DrugPatentWatch.com.